StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Net Income by Quarter

Net Income ($M)

QuarterlyAnnual

Novartis Net Income: $1,202M in Q3 2026, down 69.4% from a year earlier.

Latest, Q3 2026
1,202
Period ended Sep 30, 2026
Change on a year earlier
-69.4%
3,928 in Q3 2025
History
37 quarters
Since Q2 2017
Sources
33
Documents cited below

Where the Q3 2026 figure comes from

“|| Shareholders of Novartis AG | 1 202 | 3 928”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Postgres DB + Form 6-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNet Income ($M)Year on yearSource
Q3 2026Sep 30, 20261,202-69.4%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20263,264-19.2%Novartis 6-K (0001114448-26-000012, filed 2026-07-21) ↗
Q1 2026Mar 31, 20263,156-12.5%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 20252,409-14.5%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 20253,928+23.2%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 20254,041+24.5%Novartis 6-K (0001370368-25-000012, filed 2025-07-17) ↗
Q1 2025Mar 31, 20253,606+34.2%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 20242,818-66.8%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 20243,189+81.1%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 20243,246+40.2%Novartis 6-K (0001370368-24-000019, filed 2024-07-18) ↗
Q1 2024Mar 31, 20242,688+17.2%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2023Dec 31, 20238,480+478.4%Novartis Form 6-K (0001370368-25-000007) ↗
Q3 2023Sep 30, 20231,761+12.0%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 20232,316+36.7%Novartis 6-K (0001370368-23-000059, filed 2023-07-18) ↗
Q1 2023Mar 31, 20232,293+3.2%Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 20221,466-91.0%Novartis Form 6-K (0001370368-24-000007) ↗

Cite this data

StockData. (2026). Novartis Net Income ($M), quarterly Q2 2017–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-is-net-inc-parent

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.